v3.26.1
SCHEDULE OF CONCENTRATION RISK (Details) - USD ($)
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Product Information [Line Items]    
Revenue $ 19,208,294 $ 16,288,881
Partner A [Member]    
Product Information [Line Items]    
Revenue 11,665,341 7,710,820
Partner B [Member]    
Product Information [Line Items]    
Revenue 434,522 552,941
Partner C [Member]    
Product Information [Line Items]    
Revenue 305,979 494,797
Three Major Partners [Member]    
Product Information [Line Items]    
Revenue $ 12,405,842 $ 8,758,558
Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | Partner A [Member]    
Product Information [Line Items]    
Concentration risk percentage 60.73% 47.34%
Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | Partner B [Member]    
Product Information [Line Items]    
Concentration risk percentage 2.26% 3.39%
Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | Partner C [Member]    
Product Information [Line Items]    
Concentration risk percentage 1.59% 3.04%
Revenue Benchmark [Member] | Revenue from Rights Concentration Risk [Member] | Three Major Partners [Member]    
Product Information [Line Items]    
Concentration risk percentage 64.59% 53.77%